Both Potatoes and Beans Reduced Insulin Resistance, Weight Both Potatoes and Beans Reduced Insulin Resistance, Weight
Randomized trial showed similar effects on insulin resistance and weight after 8 weeks of a potato-based or bean-based diet.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 1, 2022 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

The TikTok Trend That Triggered a Diabetes Drug Shortage
Ozempic, a weekly injection that helps boost insulin sensitivity in people with type 2 diabetes, also suppresses appetite, which leads to weight loss. Stories of celebrities using the drug off-label to lose a few pounds have led to an explosion of interest. (Source: WebMD Health)
Source: WebMD Health - November 29, 2022 Category: Consumer Health News Source Type: news

Feeling hungry? Polyphagia is an ‘often missed’ early sign of type 2 diabetes
If your body is unable to produce enough insulin, blood sugar can't enter the cells causing hunger and extreme tiredness. (Source: Daily Express - Health)
Source: Daily Express - Health - November 22, 2022 Category: Consumer Health News Source Type: news

Musk, Sanders Both Miss the Mark Over Pricey Insulin
A tweet from a fake Eli Lilly account earlier this month claiming insulin would be free was quickly corrected by the real company, but it was enough to spark the usual finger-wagging. Sen. Bernie Sanders, who has raised his hand to take over as chair of the Senate committee overseeing healthcare,…#elililly #fakeeli #lillyaccount #usualfingerwagging #accountearlier #claiminginsulin #eli #lilly #code #shein (Source: Reuters: Health)
Source: Reuters: Health - November 21, 2022 Category: Consumer Health News Source Type: news

FDA Approves a Drug That Can Delay Type 1 Diabetes
The therapy will cost nearly $200,000. But it ’s the first treatment in 100 years to alter the course of the disease, which usually begins in adolescence. (Source: NYT Health)
Source: NYT Health - November 18, 2022 Category: Consumer Health News Authors: Gina Kolata Tags: Diabetes Drugs (Pharmaceuticals) Immune System Insulin Food and Drug Administration Sanofi SA Immunotherapy Provention Bio Inc Source Type: news

FDA Approves Second Interchangeable Insulin Product, Rezvoglar (insulin glargine-aglr)
November 18, 2022 --  The U.S. Food and Drug Administration approves the second interchangeable biosimilar insulin product to Lantus (insulin glargine), Eli Lilly’s Rezvoglar (insulin glargine-aglr). Rezvoglar is a long-acting human... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 18, 2022 Category: General Medicine Source Type: news

Insulet recalls insulin pump remote; FDA ranks it as its 'most serious type'
One of the largest medical device makers in Massachusetts has recalled a remote control for one of its insulin pumps, and the U.S. Food and Drug Administration this week gave the recall its most urgent classification. Insulet Corp. (Nasdaq: PODD) issued a voluntary recall last month for its Omnipod DASH Insulin Management System ’s Personal Diabetes Manager. The device involves two components: a wearable pump that injects insulin into the body; and a battery-powered, smartphone-like remote control… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 17, 2022 Category: Health Management Authors: Rowan Walrath Source Type: news

Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34
Mark Cuban, the tech titan, Dallas Mavericks owner, and star of ABC’s Shark Tank, moves through the world like a friendly great white, all teeth and eyes and relentless motion. When we meet on an October morning at his office in the Mavericks’ headquarters, the serial entrepreneur, 64, is wearing a long-sleeved T-shirt advertising his last investment: Mark Cuban Cost Plus Drug Co. I was there to find out why a guy who’s made billions in tech, won an NBA championship, and become perhaps the most popular businessman on reality TV was spending his time and fortune hawking generic anti-fungal medications onli...
Source: TIME: Health - November 17, 2022 Category: Consumer Health News Authors: Charlotte Alter/Dallas Tags: Uncategorized Health Care Magazine uspoliticspolicy Source Type: news

California's Plan to Make Low-Priced Insulin Could Be Example for Nation
WEDNESDAY, Nov. 16, 2022 -- California ' s plan to manufacture its own insulin could be a huge money-saver for state residents with diabetes -- and possibly be a model for other states, according to experts. Earlier this year, California announced an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 16, 2022 Category: General Medicine Source Type: news

Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.
Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set DUBLIN, Nov. 15, 2022 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), a global leader in healthcare techno... Devices, Endocrinology, Product Launch Medtronic, extended infusion set, insulin pump therapy, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2022 Category: Pharmaceuticals Source Type: news

South Africa: Over 12 Percent of South African Adults Have Diabetes - Education Is Critical to Achieve Good Outcomes
[The Conversation Africa] Over 12% of adults in South Africa have diabetes. Since 2019, researchers at the University of Pretoria have been working on the Tshwane Insulin Project. The project consists of delivering training workshops on comprehensive diabetes and hypertension management in primary care. The researchers also provide technical assistance to healthcare professionals to improve diabetes care. The Conversation Africa spoke to project manager Dr Patrick Ngassa Piotie about what diabetes is and why it's so difficult to ma (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 15, 2022 Category: African Health Source Type: news

Fake Twitter Account Falsely Said Eli Lilly Was Giving Away Insulin Fake Twitter Account Falsely Said Eli Lilly Was Giving Away Insulin
The problem started on Thursday morning when a parody Twitter account with the handle @elilillyandco said,"We are excited to announce that insulin is free now," Forbes reported.WebMD Health News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 14, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Fake Eli Lilly Twitter Account Claims Insulin Is Free, Stock Falls 4.37%
This week showed what can happen after Elon Musk instituted a new pay $8 and you can get a blue verified check mark from Twitter policy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 12, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Social Media /social-media business pharma Source Type: news

COVID Reinfection More Lethal; No, Insulin Is Not 'Free' Now; 1 in 9 Teens Smoking
(MedPage Today) -- Note that some links may require subscriptions. Compared with the first bout, the second time around with COVID infection is riskier in terms of death, hospitalization, and developing long COVID. (Nature Medicine) No, Eli Lilly... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 11, 2022 Category: Cardiology Source Type: news

How People With Diabetes Can Lower Stroke Risk
After spending nearly two decades trying to manage her Type 2 diabetes, Agnes Czuchlewski landed in the emergency room in 2015, with news that she’d just experienced a heart attack. She also learned that she had metabolic syndrome, a cluster of conditions that includes diabetes but also brings higher risk of heart disease and stroke. “Because I needed to lose quite a bit of weight when I was first diagnosed, I was focused on the number I saw on the scale, and then on my blood-sugar numbers,” recalls Czuchlewski, 68, who lives in New York City. “I didn’t realize other numbers came into play, li...
Source: TIME: Health - November 10, 2022 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Disease healthscienceclimate Source Type: news